Seeing Is Believing
Currently out of the existing stock ratings of Gregory Fraser, 44 are a BUY (91.67%), 4 are a HOLD (8.33%).
Analyst Gregory Fraser works with a stock forecast success ratio of 36.56% fulfilled within 109.57 days on average.
Gregory Fraser’s has documented 97 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 01-Mar-2024.
Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/20/2022. The price target of $11 was fulfilled within 56 days with a profit of $5.46 (98.56%) receiving and performance score of 17.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 8 months 1 days ago
0/1 (0%)
$8.35 (228.77%)
Hold
13
1 years 8 months 2 days ago
0/1 (0%)
$8.7 (202.33%)
Buy
10
1 years 11 months 7 days ago
0/1 (0%)
$4.78 (91.57%)
Buy
12
2 years 13 days ago
0/1 (0%)
$3.91 (48.33%)
Buy
20
2 years 13 days ago
0/1 (0%)
$11.91 (147.22%)
Which stock is Gregory Fraser is most bullish on?
Which stock is Gregory Fraser is most reserved on?
What Year was the first public recommendation made by Gregory Fraser?